Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Trehalose on Peri-Trochanteric Fractures
IRCT20180404039188N5Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of trehalose in peritrochanteric fracture, sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
trehalose
03
Conditions
peritrochanteric fracture
Beyond the preview
Go deeper on IRCT20180404039188N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039188N5.